[Multiple sclerosis. Chlamydia hypothesis in debate]

T Derfuss1, R Hohlfeld, E Meinl

  • 1Abteilung für Neuroimmunologie, Max-Planck-Institut für Neurobiologie, Am Klopferspitz 18A, 82152 Martinsried.

Der Nervenarzt
|November 2, 2001
PubMed

Insights

Multiple sclerosis (MS) patients show antibodies against Chlamydia pneumoniae, but these are not the cause of MS. Oligoclonal bands in cerebrospinal fluid (CSF) of MS patients do not target Chlamydia, suggesting no causal link.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Immunology

Context:

  • A potential link between Chlamydia pneumoniae infection and multiple sclerosis (MS) has been proposed.
  • Previous studies yielded conflicting results regarding C. pneumoniae presence in MS central nervous system (CNS) tissue.
  • Elevated intrathecal antibody production against C. pneumoniae is observed in some MS patients.

Purpose:

  • To investigate whether oligoclonal bands in the cerebrospinal fluid (CSF) of MS patients recognize Chlamydia pneumoniae antigens.
  • To determine if C. pneumoniae plays a causal role in the pathogenesis of multiple sclerosis.

Summary:

  • Affinity-mediated immunoblots revealed that oligoclonal bands in MS patient CSF are not directed against Chlamydia antigens.
  • In contrast, immunoglobulins from neuroborreliosis patients strongly reacted against Borrelia antigens.
  • The observed intrathecal antibody production against C. pneumoniae in MS patients is likely part of a broader, polyspecific immune response, not specific to this pathogen.

Impact:

  • Challenges the hypothesis that Chlamydia pneumoniae infection is a direct cause of multiple sclerosis.
  • Suggests that intrathecal antibody responses in neurological diseases can be polyspecific.
  • Highlights the importance of specific antigen targeting for confirming infectious agents in CNS pathogenesis.

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...